MAIA

Maia Biotechnology Inc
4.485
0.00 (0.0%)
4.485
Volume 0
Bid Price
Ask Price
News -
Day High

Low
3.10

52 Week Range

High
9.64

Day Low
Company Name Stock Ticker Symbol Market Type
Maia Biotechnology Inc MAIA AMEX Common Stock
  Price Change Change Percent Stock Price Last Traded
0.00 0.0% 4.485 04:01:06
Open Price Low Price High Price Close Price Prev Close
4.485
Trades Volume Avg Volume 52 Week Range
0 0 - 3.10 - 9.64
Last Trade Time Type Quantity Stock Price Currency
- 0 $ 4.485 USD

Period:

Draw Mode:

Maia Biotechnology Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 49.09M 10.95M 7.52M $ - $ - -1.18 -3.10
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - 24.03k 25.60%

more financials information »

Maia Biotechnology News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical MAIA Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week4.744.77974.184.3816,620-0.255-5.38%
1 Month3.554.893.374.2128,1740.93526.34%
3 Months3.844.893.253.8717,8720.64516.8%
6 Months7.009.643.105.99241,070-2.52-35.93%
1 Year4.109.643.105.92292,3380.3859.39%
3 Years4.109.643.105.92292,3380.3859.39%
5 Years4.109.643.105.92292,3380.3859.39%

Maia Biotechnology Description

MAIA Biotechnology Inc is a targeted therapy, immuno-oncology company focused on the development and commercialization of potential first-in-class drugs with novel mechanisms of action that are intended to meaningfully improve and extend the lives of people with cancer. The company's lead program is THIO, a potential first-in-class cancer telomere targeting agent in clinical development for the treatment of telomerase-positive cancer cells.